In the BioHarmony Drug Report Database
Pentostatin
Nipent (pentostatin) is a small molecule pharmaceutical. Pentostatin was first approved as Nipent on 1991-10-11. It is used to treat hairy cell leukemia in the USA. The pharmaceutical is active against adenosine deaminase. In addition, it is known to target adenosine deaminase.
Trade Name
|
Nipent |
|---|---|
Common Name
|
pentostatin |
ChEMBL ID
|
CHEMBL1580 |
Indication
|
hairy cell leukemia |
Drug Class
|
Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein)